glp 1 agonist weight loss comparison Lilly orforglipron oral GLP-1 phase 3 trial Comparing Ozempic, Wegovy and Other
Description
This was not merely a cosmetic side effect but a potentially therapeutic benefit, given that obesity underlies much of type 2 diabetes
European Orlistat Obesity Study Group
However, this does not definitively exclude the possibility of muscle-related symptoms in individual patients, as clinical trials may not capture all real-world experiences, particularly uncommon or delayed adverse effects
Peter Nkansah is a Dental-Anesthesiologist with a private practice in Toronto
